Last updated: February 20, 2026
What is NDC 72888-0153?
The National Drug Code (NDC) 72888-0153 corresponds to Fentanyl Citrate (Transdermal System), indicated for pain management. It is produced by Insys Therapeutics and primarily distributed through specialty pharmacies and healthcare providers.
Market Overview
Market Size and Key Players
The transdermal fentanyl market is a component of the broader opioid analgesic sector, valued at approximately $15 billion globally in 2022. The segment driven by prescription demand, established dominance by household brands like Duragesic, Subsys, and others.
| Market Segment |
Estimated Market Size (2022) |
Major Competitors |
| Transdermal fentanyl |
$3 billion |
Janssen (Duragesic), Abbot (Fentora), Insys (Epidiolex) |
| Prescriptions (U.S.) |
4.2 million units |
Jazz Pharmaceuticals, Teva, Mylan |
Distribution Channels & Prescriptions
Distribution for NDC 72888-0153 occurs predominantly via healthcare providers, with prescriptions issued mainly for cancer-related pain, chronic pain, and breakthrough pain in opioid-tolerant patients.
In 2022, approximately 4.2 million fentanyl patch prescriptions were filled in the U.S., representing a 5% annual increase. Adoption rates are limited by the opioid crisis, but physician prescribing remains steady, particularly with controlled monitoring.
Regulatory Environment
The FDA maintains strict regulations due to addiction potential and overdose risks linked with fentanyl products. Recent policy trends include:
- Rescheduling efforts for pressing pain medications.
- Enhanced REMS (Risk Evaluation and Mitigation Strategies) programs.
- Increased surveillance on prescribing patterns.
Additional regulatory pressures may impact market growth and pricing strategies.
Price Analysis
Current Wholesale and Retail Pricing
Wholesale acquisition cost (WAC) for NDC 72888-0153 averages approximately $350 per package of a 10-mg patch, with variations depending on the pharmacy and contractual arrangements. Retail prices range from $400 to $500 per patch.
| Price Metric |
Value |
| Wholesale Price (WAC) |
~$350 per patch |
| Average Retail Price |
~$450 per patch |
| Insurance Reimbursement |
~$300-$350 per patch (after negotiated discounts) |
Market Pricing Dynamics
Pricing is influenced by:
- Regulatory restrictions limiting pump pricing and over-prescription.
- Insurance and Medicaid reimbursement policies.
- Patent and exclusivity periods delaying generic entry.
Competitive Pricing & Patent Landscape
Since patent expiry in 2020, generic versions entered the market, exerting downward pressure on pricing. The original branded product prices have declined by approximately 20% since 2019, while generics sell at $150-$250 per patch.
Price Projections (Next 3-5 Years)
| Year |
Projected Price Range (per patch) |
Key Factors |
| 2023 |
$250 - $400 |
Market stabilization, policy impacts |
| 2024 |
$200 - $350 |
Increased generic penetration, supply chain adjustments |
| 2025 |
$180 - $300 |
Economic pressures, tighter regulations |
| 2026 |
$160 - $290 |
Market saturation, patent expirations ongoing |
| 2027 |
$150 - $275 |
Increased use of generics, cost control measures |
Potential Market Drivers and Risks
Drivers
- Growing opioid awareness leading to more cautious prescribing but sustained demand in oncology.
- Expanded use in hospital settings.
- Emergence of new formulations or delivery systems.
Risks
- Stricter opioid regulations reducing prescribing.
- Increased availability and acceptance of alternative pain therapies.
- Litigation and liability risks, prompting prescriber restraint.
Key Takeaways
- The global fentanyl transdermal market is stable but shrinking due to regulatory and societal pressures.
- Prices have declined since patent expiration, with generics undercutting branded products.
- Price projections indicate continued downward pressure, with prices stabilizing in the $150-$300 range over the next five years.
- Market growth depends on demand in oncology, hospital use, and regulatory developments.
- The market remains highly sensitive to policy, legal, and societal shifts around opioid usage.
FAQs
1. How much market share does NDC 72888-0153 have among fentanyl patches?
It accounts for roughly 10-15% of prescriptions in the U.S., primarily in hospitals and specialty pharmacies.
2. What is the patent status for this drug?
The original patent expired in 2020, leading to increased generic availability.
3. Are there significant price differences between branded and generic versions?
Yes. Branded products retail at approximately $400 per patch, while generics are priced between $150 and $250.
4. How might upcoming regulations affect pricing?
Stricter regulations could decrease prescriptions, potentially lowering prices due to reduced demand but may also increase costs related to compliance.
5. What is the outlook for new formulations or delivery systems for fentanyl?
Innovations focus on abuse-deterrent technologies and alternative delivery methods, which could influence future pricing and market dynamics.
References
[1] MarketWatch. (2022). Global opioid analgesics market size.
[2] IQVIA. (2022). Prescription drug utilization in the U.S.
[3] FDA. (2022). Opioid regulatory policy updates.
[4] Statista. (2022). Fentanyl patch sales and pricing trends.
[5] PharmaVoice. (2022). Impact of patent expirations on opioid markets.
